Table 1.
: Characteristics of the studied population
| Variables | VA–ECMO n = 9 |
Control n = 9 |
p |
|---|---|---|---|
| Gender, n (%) | 0.99 | ||
| Male | 6 (67) | 7 (77) | |
| Female | 3 (33) | 2 (23) | |
| Age, years, median (IQR) | 59 (57–63) | 56 (47–68) | 0.87 |
| BMI, kg/m2, median (IQR) | 26 (24–29) | 28 (27–35) | 0.19 |
| Diabetes, n (%) | 2 (22) | 2 (22) | 0.99 |
| Cancer, n (%) | 1 (11) | 0 | 0.99 |
| Chronic kidney disease, n (%) | 0 | 1 (11) | 0.99 |
| Chronic heart failure, n (%) | 2 (22) | 4 (44) | 0.62 |
| Tobacco use, n (%) | 4 (44) | 1 (11) | 0.29 |
| Causes of cardiogenic shock | 0.22 | ||
| Acute coronary syndrome | 7 (78) | 3 (33) | |
| Acute decompensated heart failure | 1 (11) | 4 (44) | |
| Myocarditis | 1 (11) | 1 (11) | |
| Acute stress-induced cardiomyopathy | 0 (0) | 1 (11) | |
| Highest blood lactate level, median (IQR) | 2.7 (2.3–4.2) | 3.6 (2,6–6.8) | 0.31 |
| SAPS II, median (IQR) | 45 (36–54) | 41 (34–44) | 0.39 |
| SOFA baseline, median (IQR) | 9 (7–13) | 7 (3–9) | 0.16 |
| SOFA day 1, median (IQR) | 9 (8–13) | 9 (7–9) | 0.32 |
| Mechanical ventilation duration, days, median (IQR) | 17 (9–21) | 0 (0–14) | 0.01 |
| Vasopressor use duration, days, median (IQR) | 15.5 (9.8–19.5) | 6 (3–8) | 0.049 |
| Length of hospital stay, days, median (IQR) | 17 (14–21) | 0 (0–14) | 0.001 |
| Nosocomial infection, n (%) | 5 (56) | 1 (11) | 0.13 |
| 7-day mortality, n (%) | 1 (11) | 1 (8) | 0.99 |
| 30-day mortality, n (%) | 5 (56) | 4 (30) | 0.99 |
| 90-day mortality, n (%) | 5 (56) | 6 (67) | 0.99 |
VA-ECMO, venoarterial extracorporeal membrane oxygenation; BMI, Body mass index; ICU, Intensive care unit; SAPS II, Simplified acute physiology score; SOFA, Sequential organ failure assessment